Patients with anorectal malignant melanoma (ARMM) have a poor prognosis. Optimal surgical treatment is not defined. The aim of the study was to define the surgical treatment for ARMM, to compare the overall survival (OS) of abdomino-perineal resection (APR) and wide local excision (WLE) and to study various prognostic factors. Thirty patients of ARMM were managed, 20 with locoregional disease, 10 metastatic. Of the 20 patients with locoregional disease, 15 underwent APR and 5 WLE. The 1-, 2-, 3-, and 4-year overall survival rates (by Kaplan–Meier survival analysis) in the APR group were 67, 40, 40, and 32%, and in WLE group were 100, 100, 67, and 67% respectively. Median survival for APR and WLE groups were 13 and 36 months and were not significant (p 0.48). Node-negative patients had better survival than node positive in the APR group (56 vs. 13 months) (p 0.017). Patients with tumor size < 2cm, lymphovascular invasion and perineural invasion negative, and margin-negative and with superficial infiltration had a trend toward better survival than their counterparts. WLE gives an equivalent oncological outcome and can be offered for patients with smaller ARMM and APR for locally advanced, larger tumors or as a salvage following recurrence after WLE.
Anorectal malignant melanoma Abdomino-perineal resection Wide local excision Survival
anorectal malignant melanoma
wide local excision
This is a preview of subscription content, log in to check access.
Compliance with Ethical Standards
This study was approved by ethics committee of Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Chang AE, Karnell LH, Menck HR (1998) The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83(8):1664–1678CrossRefGoogle Scholar
Ben-Izhak O, Bar-Chana M, Sussman L, Dobiner V, Sandbank J, Cagnano M, Cohen H, Sabo E (2002) Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma. Histopathology 41:519–525CrossRefGoogle Scholar
Brady MS, Kavolius JP, Quan SH (1995) Anorectal melanoma: a 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum 38(2):146–151CrossRefGoogle Scholar
Whooley BP, Shaw P, Astrow AB et al (1998) Long-term survival after locally aggressive anorectal melanoma. Am Surg 64(3):245–251PubMedGoogle Scholar
Podnos YD, Tsai NC, Smith D et al (2006) Factors affecting survival in patients with anal melanoma. Am Surg 72(10):917–920PubMedGoogle Scholar
Weyandt GH, Eggert AO, Houf M et al (2003) Anorectal melanoma: surgical management guidelines according to tumour thickness. Br J Cancer 89(11):2019–2022CrossRefGoogle Scholar
Matsuda A, Miyashita M, Matsumoto S et al (2015) Abdominoperineal resection provides better local control but equivalent overall survival to local excision of anorectal malignant melanoma: a systematic review. Ann Surg 261(4):670–677CrossRefGoogle Scholar
Kiran RP, Rottoli M, Pokala N et al (2010) Long-term outcomes after local excision and radical surgery for anal melanoma: data from a population database. Dis Colon Rectum 53(4):402–408CrossRefGoogle Scholar
Nilsson PJ, Ragnarsson-Olding BK (2010) Importance of clear resection margins in anorectal malignant melanoma. Br J Surg 97(1):98–103CrossRefGoogle Scholar
Ross M, Pezzi C, Pezzi T et al (1990) Patterns of failure in anorectal melanoma: a guide to surgical therapy. Arch Surg 125(3):313–316CrossRefGoogle Scholar